Controlled Clinical Studies
Controlled Clinical Studies - Related Videos
08:33
Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
0 Views •
Cited by 4 •
2022
The protocol describes the settings and use of a capillary aerosol generator for continuous production of controlled aerosol from a multispecies liquid solution, suitable for steady large-volume aerosol delivery (e.g., in vivo inhalation studies).
01:23
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
0 Views •
2024
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy. Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
06:09
Studying the Protein Quality Control System of D. discoideum Using Temperature-controlled Live Cell Imaging
0 Views •
2016
The social amoebae Dictyostelium discoideum has recently been established as a system to study protein misfolding and proteostasis. Here, we describe a new imaging-based methodology to study temperature-induced protein aggregation and the cellular stress response in D. discoideum.
01:21
Aneurysm II: Clinical Manifestations and Diagnostic Studies
0 Views •
2025
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:30
Hypertension III: Clinical Manifestations and Diagnostic Studies
0 Views •
2025
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
FAQs
Randomization assigns participants to intervention or control groups according to a planned method rather than researcher or participant preference. This helps reduce systematic differences between groups that could otherwise influence outcomes. When appropriate, randomization makes it easier to attribute observed differences to the intervention instead of to preexisting characteristics or uneven disease variation.
Blinding limits knowledge of which participants receive the intervention or control condition when that approach is appropriate. By reducing expectations and observer influence, it can help distinguish treatment effects from placebo responses and other sources of bias. Its use depends on the intervention and study design, so it is not required in every investigation.
Eligibility criteria specify which participants can enter a study, creating a consistent basis for evaluating the intervention in the intended population. Predefined outcome measures identify what researchers will assess, such as benefits, risks, safety, or efficacy. Together, these elements keep the investigation focused and support more interpretable comparisons between study groups.
The control group provides a comparison for changes that might occur without the intervention, including natural disease variation and placebo responses. Researchers can then examine whether outcomes differ between participants receiving the intervention and those in the control condition. This comparison strengthens interpretation of whether the intervention contributed to the observed result.
Controlled clinical studies can be conducted across phases of clinical research, with each phase contributing evidence at a different point in development. The structured design allows investigators to examine the intervention's safety and efficacy while following predefined eligibility criteria and outcome measures. Findings from these phases help determine whether further clinical investigation is warranted.
These investigations can assess drugs, medical devices, behavioral interventions, and diagnostic approaches. Their outcome data may clarify benefits, risks, safety, and efficacy, depending on the study purpose and predefined measures. The resulting evidence can inform patient care, support regulatory decisions, and identify unresolved questions for future clinical investigation.